Australian biotechs have unearthed a new pot of gold and it has nothing to do with drugs and experimental therapies. Testing had become the latest boom industry. generating hundred of millions of dollars for local firms, as they win contracts in the world’s biggest health market: the US.
Clinical diagnostics company Envision Sciences has appointed Scott Richards as its new chief executive officer. Envision is developing and commercialising a pipeline of novel biomarker-based cancer diagnostic and prognostic tests in tissue and blood. Mr Richards has over 35 years of experience in the global pharmaceutical industry, leading significant commercial-stage enterprises in Australia, Europe and […]
Lab service utilizes Envision Science’s proprietary biomarkers and technology with a goal of improving diagnosis and grading of prostate cancer SECAUCUS, N.J. and MELBOURNE, Australia, July 13, 2023 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, today announced the launch of a novel prostate cancer biomarker test through its subspecialty pathology […]